- Guidance and resources
- Health facilities
- Therapeutics for COVID-19
- Reporting COVID-19 cases
- Specimen collection, reporting and delivery
- Surveillance
- Vaccination providers
Healthcare Provider Guidance and Resources
- CDC Infection Control Recommendations for Healthcare Professionals During COVID-19
- Guidance for Discontinuation of Isolation and Transmission-Based Precautions in Patients with COVID-19
- Discharge Guidance for Suspected or Confirmed COVID-19 Patients
- NIH Clinical Guidelines: Therapies for High-Risk, Nonhospitalized Patients
- NIH Panel's Statement on Prioritizing the Use of Outpatient Therapies
- CDC Guidance for Healthcare Personnel with Potential COVID-19 Exposure
- Handout: What to Do After You Have Been Tested for COVID-19
- Handout: Home Isolation for Individuals with COVID-19
- Handout: Instructions for Individuals with COVID-19 Exposure (Self-Quarantine)
- CDC guidance related to COVID-19
Patient Handouts
- What to Do After You Have Been Tested for COVID-19
- Home Isolation for Individuals with COVID-19
- Instructions for Individuals with COVID-19 Exposure (Self-Quarantine)
- Bebtelovimab fact sheet FDA
- Evusheld fact sheet FDA
- Molnupiravir fact sheet FDA
- Paxlovid fact sheet FDA
Vaccination Providers
COVID-19 Therapeutics
- Therapeutics locator
- Billing for COVID-19 therapeutics
- Monoclonal antibody therapy
- Evusheld
- Oral antivirals
- Remdesivir
- Contact information for Mississippi COVID-19 therapeutics providers PDF
- Overview of Therapeutics for the Prevention or Treatment of COVID-19 (HHS.gov) PDF
Monoclonal Antibody Therapy
Use of a monoclonal antibody product is determined by variants in your geographic area.
Ordering: The federal government has designed the Healthcare Provider Order Portal (HPOP) for management of COVID-19 therapeutics. At the current time, only the state can place orders for monoclonal antibodies in HPOP. You will be able to see courses ordered for your site on your HPOP account.
Required reporting: Weekly utilization must be reported to HHS and MSDH. To register your site for HHS reporting, e-mail hhs-protect@teletracking.com. To register your site for MSDH reporting, e-mail contact information to C19Therapeutics@msdh.ms.gov
Resources:
- COVID-19 Therapeutics Decision Aid
- COVID-19 Monoclonal Antibody Therapeutics Calculator for Infusion Sites
- Mississippi Monoclonal Antibody Providers
- Outpatient Administration Playbook for Healthcare Leadership
- Bamlanivimab/etesevimab resources from Lilly.com
- Bebtelovimab resources Lilly
- REGEN-COV resources from Regeneron.com
- Sotrovimab resources
Evusheld
Ordering: The federal government has designed the Healthcare Provider Order Portal (HPOP) for management of COVID-19 therapeutics. At the current time, only the state can place orders for Evusheld in HPOP. You will be able to see courses ordered for your site on your HPOP account.
Required reporting: Courses administered and courses available of Evusheld should be entered into HPOP by the provider site at the end of every business day. Timely and accurate inventory reporting is necessary for federal partners to determine subsequent state allocations.
Resources:
- Evusheld fact sheet for healthcare providers FDA
- Evusheld fact sheet for patients/caregivers FDA
- Video: COVID-19 Prevention for Special Populations and related links March 2022
Oral Antivirals
Ordering: The federal government has designed the Healthcare Provider Order Portal (HPOP) for management of COVID-19 therapeutics. At the current time, only the state can place orders for for oral antivirals in HPOP. You will be able to see courses ordered for your site on your HPOP account.
Required reporting: Courses administered and courses available of Paxlovid and molnupiravir should be entered into HPOP by the provider site at the end of every business day. Timely and accurate inventory reporting is necessary for federal partners to determine subsequent state allocations
Resources:
- Molnupiravir resources from Merck.com
- Molnupiravir fact sheet for healthcare providers (FDA)
- Molnupiravir fact sheet for patients/caregivers (FDA)
- New Paxlovid Dose Pack Authorized by FDA (HHS) April 14, 2022
- PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers (FDA) May 4, 2022
- Paxlovid resources
- Paxlovid fact sheet for healthcare providers (FDA)
- Paxlovid fact sheet for patients/caregivers (FDA)
Find pharmacies that dispense oral antivirals
Therapeutics Locator
Use this interactive map to locate a facility that has one of the authorized therapeutics for COVID-19.
Presentation: Oral Antiviral Therapeutics
Overview and details of use, safety, interactions, target population and more (May 12, 2022)
Remdesivir
Remdesivir has been student in non-hospitalized patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease and is approved by the FDA for use in both hospitalized and non-hospitalized patients.
Ordering: Remdesivir is commercially available and should be ordered through standard pharmaceutical procurement processes.
Billing for COVID-19 Therapeutics
Reporting COVID-19 Cases
- Electronic Reporting of COVID-19 Test Results to MSDH
Options and data formats - Request NBS Account for COVID-19 Reporting
Choose this option if you run non-rapid, non-point-of-care COVID-19 tests (typically hospitals, reference labs, large clinic systems, etc.) - Sign up for Simple Report for COVID-19 Reporting
This reporting tool only works with rapid and point-of-care COVID-19 tests (typically clinics, schools, and non-traditional testing sites).
Note: Simple Report allows facilities to view and edit all data entered for their facility.
COVID-19 Deaths
- Death Reporting Q & A for Medical Examiners, Coroners and Physicians
- CDC Guidance on Certifying COVID-19 Deaths PDF
- MSDH Guidance for Funeral Homes and Mortuaries PDF
- How to get a Mississippi death certificate PDF
Health Facilities
Specimen Collection, Delivery and Reporting
- COVID-19 Specimen Collection
- COVID-19 Lab Requisition Form
- COVID-19 Refrigerated Specimen Packaging
- COVID-19 Frozen Specimen Packaging
- COVID-19 Specimen Transport and Delivery
Specimen Reporting
SARS-CoV-2 Virus Strain Surveillance
- COVID-19 Enhanced Surveillance Submission Recommendations
- SARS-CoV-2 Enhanced Surveillance Submission Requisition Form 1198
Map and Directions for Laboratory Dropoff
The Dr. F.E.”ED” Thompson, Jr. Public Health Laboratory Facility is on the State Department of Health's central office campus in Jackson, MS at 350 East Woodrow Wilson Drive, Jackson, 39216.
Local Delivery of Samples: Drop samples off at the rear of the Thompson lab building. Detailed instructions are in our sample shipping guidance.
Dropoff hours: Monday through Friday from 8:00–4:30.
Mississippi Health Alert Network
CDC Guidance
Healthcare and EMS
- Home Care Guidance
- Discontinuation of Home Isolation for Persons with COVID-19
- Healthcare Infection Control Guidance
- Clinical Care Guidance
- Healthcare Personnel with Potential COVID-19 Exposure Guidance
- Inpatient Obstetric Healthcare Guidance
- Guidance for EMS
Persons Under Investigation (PUI)
- Evaluating PUIs and Asymptomatic Close Contacts of Confirmed Cases
- Collection and Submission of Postmortem Specimens from Deceased PUI
Other Guidances
- Strategies for optimizing the supply of N95 respirators
- Guidance for extended use of N95 respirators in healthcare settings
